DexCom Inc. Files 2024 Q2 10-Q Report
Ticker: DXCM · Form: 10-Q · Filed: 2024-07-25T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, quarterly-report, medical-devices
Related Tickers: AMZN, GOOG, MSFT
TL;DR
DexCom's Q2 2024 10-Q is in. Financials and business updates are here.
AI Summary
DexCom Inc. filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter of 2024, detailing financial performance and operational updates. Key financial figures and business segments are presented for the reporting period and comparative periods.
Why It Matters
This report provides investors with crucial financial data and insights into DexCom's performance in the second quarter of 2024, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.
Key Numbers
- 2024 Q2 — Reporting Period (Second quarter of 2024)
- 2024-06-30 — End of Reporting Period (Specific date for financial data)
- 2023-12-31 — Prior Year End (For comparative financial analysis)
Key Players & Entities
- DEXCOM INC (company) — Filer
- 20240630 (date) — Period of Report
- 20240725 (date) — Filing Date
- SAN DIEGO (location) — Business Address City
- 8582000200 (phone_number) — Business Phone
FAQ
What is the primary business of DexCom Inc. according to the filing?
DexCom Inc. is listed under the Standard Industrial Classification code 3841 for Surgical & Medical Instruments & Apparatus.
What is the filing date of this 10-Q report?
The filing date is 20240725.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending 20240630, which is the second quarter of 2024.
Where is DexCom Inc. headquartered?
DexCom Inc.'s business address is in San Diego, CA.
What is the SEC file number for DexCom Inc.?
The SEC file number for DexCom Inc. is 000-51222.
From the Filing
0001093557-24-000144.txt : 20240725 0001093557-24-000144.hdr.sgml : 20240725 20240725171818 ACCESSION NUMBER: 0001093557-24-000144 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 82 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240725 DATE AS OF CHANGE: 20240725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 241142900 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 10-Q 1 dxcm-20240630.htm 10-Q dxcm-20240630 false 2024 Q2 0001093557 12/31 0.0243476 0.0061571 0.006662 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure dxcm:purchaser utr:D dxcm:segment dxcm:primaryMarket 0001093557 2024-01-01 2024-06-30 0001093557 2024-07-18 0001093557 2024-06-30 0001093557 2023-12-31 0001093557 2024-04-01 2024-06-30 0001093557 2023-04-01 2023-06-30 0001093557 2023-01-01 2023-06-30 0001093557 us-gaap:CommonStockMember 2024-03-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001093557 us-gaap:RetainedEarningsMember 2024-03-31 0001093557 us-gaap:TreasuryStockCommonMember 2024-03-31 0001093557 2024-03-31 0001093557 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001093557 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001093557 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0001093557 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001093557 us-gaap:CommonStockMember 2024-06-30 0001093557 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001093557 us-gaap:RetainedEarningsMember 2024-06-30 0001093557 us-gaap:TreasuryStockCommonMember 2024-06-30 0001093557 us-gaap:CommonStockMember 2023-03-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001093557 us-gaap:RetainedEarningsMember 2023-03-31 0001093557 us-gaap:TreasuryStockCommonMember 2023-03-31 0001093557 2023-03-31 0001093557 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001093557 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0001093557 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001093557 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001093557 us-gaap:CommonStockMember 2023-06-30 0001093557 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001093557 us-gaap:RetainedEarningsMember 2023-06-30 0001093557 us-gaap:TreasuryStockCommonMember 2023-06-30 0001093557 2023-06-30 0001093557 us-gaap:CommonStockMember 2023-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001093557 us-gaap:RetainedEarningsMember 2023-12-31 0001093557 us-gaap:TreasuryStockCommonMember 2023-12-31 0001093557 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001093557 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0001093557 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-06-30 0001093557 us-gaap:RetainedEarningsMember 2024-01-01 2024-06-30 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-06-30 0001093557 us-gaap:CommonStockMember 2022-12-31 0001093557 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001093557 us-gaap:AccumulatedOtherComprehensiveIncomeMemb